The monoclonal antibodies are referred to as man-made identical immunoglobulins developed from single B-cell with specific target antigens. They stimulate the patient’s immune system and prevents the disease by blocking the specific cell receptors. The demand of monoclonal antibodies are becoming ubiquitous in the treatment of different types of cancer mostly in developed countries. The growing demand for its use in pre-clinical in-vitro and in-vivo testing. However, factors such as high-cost and time-intensive antibody development process have limited market growth. In addition, major companies in the market have participated in the launch of new products to strengthen their position in the market.
MARKET SCOPE
The "Global Monoclonal Antibodies Market Analysis to 2028" is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Monoclonal Antibodies market with detailed market segmentation by source, production, indication, application, and end user, and geography. The report provides key statistics on the market status of the leading Monoclonal Antibodies market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
-Based on source, the global Monoclonal Antibodies market is segmented into murine, chimeric, humanized, human
-Based on production, the market is classified into in vivo and in vitro
-Based on indication, the market is subcategorized into cancer, autoimmune diseases, inflammatory diseases, infectious diseases, microbial diseases, others
-Based on application, the market is bifurcated into diagnostic applications, therapeutic application, research applications
-Based on end user, the market is bifurcated into hospitals, research institutes, and others
Drivers-
-Rise in the prevalence of various types of cancer
-Increase in the demand of cost-effective biosimilar monoclonal antibodies
-Time Intensive antibod development process
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Monoclonal Antibodies market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Monoclonal Antibodies market in these regions.
IMPACT OF COVID-19 ON MONOCLONAL ANTIBODIES MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.
MARKET PLAYERS
The report covers key developments in the Monoclonal Antibodies market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from Monoclonal Antibodies market are anticipated to lucrative growth opportunities in the future with the rising demand for Monoclonal Antibodies in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Monoclonal Antibodies market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
-Novartis AG
-Pfizer Inc.
-GlaxoSmithKline plc.
-Amgen Inc
-DAIICHI SANKYO COMPANY, LIMITED
-F. Hoffmann-La Roche Ltd.
-AstraZeneca
-Eli Lilly and Company
-Bayer AG
-Bristol-Myers Squibb Company